FDA under pressure to establish staff social media policy
24 March 2015
Advocacy group Union of Concerned Scientists (UCS) has found a new reason to grumble about how the FDA handles social media. Having faced years of criticism for its failure to publish guidelines on how the industry can use social media, the FDA is now being chastised over its lack of a policy for its staff.
India plans pharma manufacturing clusters to ease costs
24 March 2015
India's health ministry said the government plans to spend $27.3 million to establish 10 clusters around the country for drugmakers to share common production facilities and reduce their costs by 25%.
24 March 2015
The enactment of the Affordable Care Act with its expansion of Medicaid benefits has led to an uptick in diabetes diagnoses by almost one-quarter, according to a study of deidentified test results from Quest Diagnostics ($DGX). That's in states that opted to expand Medicaid under the new law during the first 6 months of 2014 as compared to the first 6 months of 2013.
Biotech spared in U.K. rejig of VC trusts
24 March 2015
The United Kingdom is to change the laws governing startup investment vehicles known as Venture Capital Trusts (VCTs) but has opted against some of the dramatic alterations previously mooted. VCTs will still face new restrictions on the companies to which they can provide private equity cash, though.
Cancer immunotherapy is racking up more successes
23 March 2015
Immunotherapy can deliver remissions that last long enough to make the most hardened oncologist consider the possibility that their patient might be cured. But only a minority of patients responds to immunotherapy at all.
China guidelines on stem cell research, treatments possible by summer
23 March 2015
China could have guidelines governing stem cell and similar research and treatments by midsummer, the China FDA said in a meeting with local experts in the field.
23 March 2015
Under pressure from the scientific community, the Australian government has funded research facilities there that were facing closure, Nature News reports.
EMA celebrates 20 years, looks to complex future
23 March 2015
he best way to celebrate is to start preparing the European Medicines Agency [EMA] for the future." This was the call to arms from Guido Rasi, principal adviser in charge of strategy at the EMA, opening the agency's 20th anniversary celebration conference here on Wednesday.
Big Pharma's market cap stars of 2014
23 March 2015
Who can resist a numbers match-up? Not us, obviously. Even better when the winners are a bit unexpected. Today, it's market cap, courtesy of EvaluatePharma and its annual state of the industry report.
NovaMedica helps ophthalmologists getting new knowledge
20 March 2015
NovaMedica participated in the annual conference “The 14th All-Russian Ophthalmologist School 2015” near Moscow. The event welcomed more than 200 medical specialist from all over Russia. The opinion leaders’s reports and presentations covered various issues of therapeutical and surgical ophtalmology.
06 September 2024
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
87% of cancer patients give positive ratings for medical care quality
18 September 2024
The Russian market of fillers and biorevitalizers grew by 21% in the first half of 2024
18 September 2024
Pharma’s Patient Reach Problem: Billions Still Left Behind
17 September 2024
17 September 2024